ClinicalTrials.govpublic full text
Phase 2b Study in NASH to Assess IVA337
non-alcoholic steatohepatitis (nash), non-alcoholic steatohepatitis, nash, peroxisome proliferator-activated receptor (ppar), liver diseases, fibrosis, fatty liver, non-alcoholic fatty liver disease, digestive system diseases, iva337, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800944
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.